Learn / SGMT
NASDAQ: SGMT
Sagimet Biosciences (SGMT) stock, explained like you're 5
Sagimet Biosciences trades on the Nasdaq under the ticker SGMT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 630 million dollars.
- Ticker
- SGMT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 630 million dollars
Is Sagimet Biosciences a small, medium or large cap company?
No. Sagimet Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 630 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Sagimet Biosciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves SGMT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Sagimet Biosciences Inc. (SGMT) stock price, news, quote and history (Yahoo Finance UK)
- $SGMT stock is down 9% today. Here's what we see in our data. (Quiver Quantitative)
- Sagimet Biosciences (NasdaqGM:SGMT) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Sagimet raised about $115 million, with an acne drug trial among its planned uses. (Stock Titan)
- Sagimet Biosciences Inc. (SGMT) Options Chain (Yahoo! Finance Canada)
Follow SGMT in your daily brief
Each trading day at 5 PM ET we post what happened to Sagimet Biosciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow SGMT
Questions about Sagimet Biosciences stock
What does Sagimet Biosciences do?
Sagimet Biosciences trades on the Nasdaq under the ticker SGMT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 630 million dollars.
What is the ticker symbol for Sagimet Biosciences?
Sagimet Biosciences trades under the ticker SGMT on the Nasdaq.
What is Sagimet Biosciences's market cap?
Sagimet Biosciences is a small cap stock with a market cap of about 630 million dollars.
How does Sagimet Biosciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves SGMT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow SGMT stock every day?
Add SGMT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.